CRH Medical (CRHM) Stock Price, News & Analysis

Company Overview

CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 70 ambulatory surgical/endoscopy centers in 14 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: $3.99 to $4.00
• 50-Day Range: N/A
• 52-Week Range: $1.66 to $4.01
• Volume: 388,400 shs
• Average Volume: 1.04 million shs
• Market Capitalization: $285.76 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CRHM Stock Analysis - Frequently Asked Questions

How were CRH Medical's earnings last quarter?

CRH Medical Co. (NYSEAMERICAN:CRHM) announced its earnings results on Thursday, November, 12th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). The company earned $30.35 million during the quarter, compared to analyst estimates of $29.50 million. CRH Medical had a negative net margin of 4.12% and a negative trailing twelve-month return on equity of 3.37%.

How do I buy shares of CRH Medical?

Shares of CRHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CRH Medical investors own include CRH Medical (CRH), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), AcelRx Pharmaceuticals (ACRX), Ampio Pharmaceuticals (AMPE), Extreme Networks (EXTR) and Palatin Technologies (PTN).

Company Calendar

• Last Earnings: 11/12/2020
• Today: 1/21/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Medical
• Industry: Health Services
• Sub-Industry: Healthcare
• Current Symbol: NYSEAMERICAN:CRHM
• Previous Symbol: NYSEARCA:CRHM
• CUSIP: N/A
• CIK: N/A
• Web: investors.crhsystem.com
• Phone: +1-604-6331440
• Fax: N/A
• Employees: 133
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.05
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.77 million
• Net Margins: -4.12%
• Pretax Margin: N/A
• Return on Equity: -3.37%
• Return on Assets: -2.03%

Debt

• Debt-to-Equity Ratio: 0.60
• Current Ratio: 2.63
• Quick Ratio: 2.60

Sales & Book Value

• Annual Sales: $120.39 million
• Price / Sales: 2.37
• Cash Flow: $0.99 per share
• Price / Cash Flow: 4.02
• Book Value: $1.73 per share
• Price / Book: 2.31

Miscellaneous

• Outstanding Shares: 71,620,000
• Free Float: N/A
• Market Cap: $285.76 million
• Optionable: Not Optionable
• Beta: 2.41